Top Markets
Coin of the day
BioNexus Gene Lab Corporation BioNexus Gene Lab Corporation

BioNexus Gene Lab Corporation

BGLC
주식 순위 #18714
BioNexus Gene Lab Corporation, a molecular diagnostics company, focuses on... BioNexus Gene Lab Corporation, a molecular diagnostics company, focuses on developing and commercializing molecular diagnostic tests for the early detection of diseases and personalized health management primarily in Malaysia. Its non-invasive blood tests are used to analyze changes in ribonucleic acid for the detection of Covid-19, Dengue, human immunodeficiency virus, human papillomavirus, and the risk potentiality of cancers diseases. BioNexus Gene Lab Corporation was incorporated in 2017 and is based in Kuala Lumpur, Malaysia with an additional office in Sheridan, Wyoming.
주가
$2.49
시가총액
$4.47M
변동 (1일)
-4.01%
변동 (1년)
678.16%
국가
MY
거래 BioNexus Gene Lab Corporation (BGLC)

카테고리

BioNexus Gene Lab Corporation (BGLC)의 EPS
September 2025 기준 EPS TTM: $-1.27
BioNexus Gene Lab Corporation의 최신 재무 보고서와 주가에 따르면, 현재 EPS (TTM)는 $-1.27입니다. 2023년 말에는 회사의 EPS가 $-1.53였으며, 이는 2022년의 EPS $-0.25와 증가입니다.
BioNexus Gene Lab Corporation의 EPS 기록 (2016 ~ 2026)
매년 말의 EPS
연도 EPS 변화
2026 (TTM) $-1.27 41.11%
2024 $-0.90 -41.18%
2023 $-1.53 512.00%
2022 $-0.25 -147.17%
2021 $0.53 -58.59%
2020 $1.28 -3,842.69%
2019 $-0.03 -812.50%
2018 0.00 -124.12%
2017 $-0.02 19,800.00%
2016 0.00 0.00%
유사 기업 또는 경쟁사의 EPS
회사 EPS EPS 차이 국가
$17.77 -1,499.21%
US
$5.07 -499.21%
US
$13.17 -1,137.01%
US
$0.74 -158.17%
CN
$4.54 -457.48%
US